We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Markers in Blood Can Help Identify Risk for Complications After Mild TBI
News

Markers in Blood Can Help Identify Risk for Complications After Mild TBI

Markers in Blood Can Help Identify Risk for Complications After Mild TBI
News

Markers in Blood Can Help Identify Risk for Complications After Mild TBI

Credit: rawpixel
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Markers in Blood Can Help Identify Risk for Complications After Mild TBI"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Molecules released into the blood following mild traumatic brain injury (TBI) may be indicators of neuronal damage associated with conditions such as post-traumatic stress disorder (PTSD) and depression, researchers from the National Institute of Nursing Research (NINR), part of the National Institutes of Health, have found. This study included military veterans and servicemembers who were enrolled in the Chronic Effects of Neurotrauma Consortium (CENC) multicenter observational study of the long-term effects of mild TBI and was published in Neurology.

“This study brings us closer to identifying biomarkers to predict risk for PTSD, depression, and similar conditions in military personnel and others who have experienced a traumatic brain injury,” said Jessica Gill, Ph.D., R.N., F.A.A.N., deputy scientific director, and acting deputy director, NINR, and chief of NINR’s Tissue Injury Branch, who conducted the study with colleagues.

The researchers analyzed blood samples from former military personnel who had experienced one to two TBIs, more than two TBIs, or no TBIs. They screened for molecules released directly into the blood by cells of damaged tissue or inside vesicles called exosomes—bubble-like structures that contain a representative sample of cellular molecules. There was a significant correlation between multiple mild TBIs across the lifespan and higher levels of neurofilament light (NfL), a structural protein found inside neurons, and molecules involved in inflammation, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6).

Further analysis revealed associations between increases in plasma and exosome levels of NfL, length of time since the last TBI, multiple TBIs, and increased severity of neurological and behavioral symptoms. These findings provide insights into potential mechanisms of TBI-associated neuroinflammatory and neurodegenerative processes correlated with persistent molecular effects of neuronal damage.

Reference

Guedes et al. (2020). Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury?. Neurology. DOI: https://doi.org/10.1212/WNL.0000000000009577

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement